Luiz Fernando Caneo

Luiz Fernando Caneo

Auto-generated profile, based on publicly available information

Luiz Fernando Caneo

Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
CDCarlos A. Dias
Carlos A. Dias
RARenato S. Assad
Renato S. Assad
LCLuiz F. Caneo
Luiz F. Caneo
MAMaria Cristina D. Abduch
Maria Cristina D. Abduch
Vera AielloVera Aiello
Vera Aiello
SOSérgio A. Oliveira
Sérgio A. Oliveira

4 December 2017 in Cardiology in the Young
Verified
Journal Article
Open access
PDF file
PIParvathi U. Iyer
Parvathi U. Iyer
GMGuillermo E. Moreno
Guillermo E. Moreno
LCLuiz Fernando Caneo
Luiz Fernando Caneo
TFTahira Faiz
Tahira Faiz
LSLara S. Shekerdemian
Lara S. Shekerdemian
KIKrishna S. Iyer
Krishna S. Iyer
In many parts of the world, mostly low- and middle-income countries, timely diagnosis and repair of congenital heart diseases (CHDs) is not feasible for a variety of reasons. In these regions, economic growth has enabled the development of cardiac units that manage patients with CHD presenting later than would be ideal, often after the window for early stabilisation – transposition of the great arteries, coarctation of the aorta – or for lower-risk surgery in infancy – left-to-right shunts or cyanotic conditions. As a result, patients may have suffered organ dysfunction, manifest signs of pulmonary vascular disease, or the sequelae of profound cyanosis and polycythaemia. Late presentation poses unique clinical and ethical challenges in decision making regarding operability or surgical candidacy, surgical strategy, and perioperative intensive care management.

12 May 2017 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
ATAída L. R. Turquetto
Aída L. R. Turquetto
LCLuiz F. Canêo
Luiz F. Canêo
DADaniela R. Agostinho
Daniela R. Agostinho
POPatrícia A. Oliveira
Patrícia A. Oliveira
MLMaria Isabel C. S. Lopes
Maria Isabel C. S. Lopes
MJMarcelo B. Jatene
Marcelo B. Jatene

1 January 2017 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
LCLuiz Fernando Canêo
Luiz Fernando Canêo
RNRodolfo Neirotti
Rodolfo Neirotti

1 November 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
ATAida Luiza Ribeiro Turquetto
Aida Luiza Ribeiro Turquetto
MSMarcelo Rodrigues dos Santos
Marcelo Rodrigues dos Santos
ASAna Luiza Carrari Sayegh
Ana Luiza Carrari Sayegh
FSFrancis Ribeiro de Souza
Francis Ribeiro de Souza
DADaniela Regina Agostinho
Daniela Regina Agostinho
MJMarcelo Biscegli Jatene
Marcelo Biscegli Jatene

1 January 2014 in Revista Brasileira de Terapia Intensiva
Verified
Journal Article
Open access
MPMarcelo Park
Marcelo Park
EGERICC research group
ERICC research group
ELECMO group of the Hospital Sírio Libanês
ECMO group of the Hospital Sírio Libanês
HPHospital das Clínicas de São Paulo
Hospital das Clínicas de São Paulo
PMPedro Vitale Mendes
Pedro Vitale Mendes
ETEvelinda Marramon Trindade
Evelinda Marramon Trindade
To analyze the cost-utility of using extracorporeal oxygenation for patients with severe acute respiratory distress syndrome in Brazil. A decision tree was constructed using databases from previously published studies. Costs were taken from the average price paid by the Brazilian Unified Health System (Sistema Único de Saúde; SUS) over three months in 2011. Using the data of 10,000,000 simulated patients with predetermined outcomes and costs, an analysis was performed of the ratio between cost increase and years of life gained, adjusted for quality (cost-utility), with survival rates of 40 and 60% for patients using extracorporeal membrane oxygenation. The decision tree resulted in 16 outcomes with different life support techniques. With survival rates of 40 and 60%, respectively, the increased costs were R$=-301.00/-14.00, with a cost of R$=-30,913.00/-1,752.00 paid per six-month quality-adjusted life-year gained and R$=-2,386.00/-90.00 per quality-adjusted life-year gained until the end of life, when all patients with severe ARDS were analyzed. Analyzing only patients with severe hypoxemia (i.e., a ratio of partial oxygen pressure in the blood to the fraction of inspired oxygen <100 mmHg), the increased cost was R$=-5,714.00/272.00, with a cost per six-month quality-adjusted life-year gained of R$=-9,521.00/293.00 and a cost of R$=-280.00/7.00 per quality-adjusted life-year gained. The cost-utility ratio associated with the use of extracorporeal membrane oxygenation in Brazil is potentially acceptable according to this hypothetical study.